No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
Stifel Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $72
Conmed Highlights Growth Strategy at Healthcare Conference
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating
The Three-year Underlying Earnings Growth at CONMED (NYSE:CNMD) Is Promising, but the Shareholders Are Still in the Red Over That Time